Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as stent systems, balloon catheters, and guide wires for the treatment of peripheral, and coronary artery diseases. Biotronik has manufacturing facilities in Germany, Singapore, Switzerland, and the US. Biotronik is headquartered in Berlin, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biotronik SE & Co KG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Biotronik SE & Co KG Company Overview
- Biotronik SE & Co KG Company Snapshot
- Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
- Biotronik SE & Co KG - Pipeline Analysis Overview
- Business Description
- Biotronik SE & Co KG - Key Facts
- Biotronik SE & Co KG - Major Products and Services
- Biotronik SE & Co KG Pipeline Products by Development Stage
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
- Biotronik SE & Co KG Pipeline Products Overview
- AI Based Telemedicine - Myocardial Infarction
- AI Based Telemedicine - Myocardial Infarction Product Overview
- Allevia
- Allevia Product Overview
- AMS-2
- AMS-2 Product Overview
- Amvia Stellar
- Amvia Stellar Product Overview
- BIOVALVE Resheathable Transcatheter Aortic Valve
- BIOVALVE Resheathable Transcatheter Aortic Valve Product Overview
- Cardiac Conduction System
- Cardiac Conduction System Product Overview
- Coronary Stent System
- Coronary Stent System Product Overview
- Delivr
- Delivr Product Overview
- DREAMS 3G System
- DREAMS 3G System Product Overview
- DREAMS 3G System Clinical Trial
- ElePulse System
- ElePulse System Product Overview
- ElePulse System Clinical Trial
- Freesolve BTK RMS
- Freesolve BTK RMS Product Overview
- Hatriq
- Hatriq Product Overview
- Implantable Pressure Sensor
- Implantable Pressure Sensor Product Overview
- Magmaris Bioresorbable Magnesium Scaffold
- Magmaris Bioresorbable Magnesium Scaffold Product Overview
- Magmaris Bioresorbable Magnesium Scaffold Clinical Trial
- ProGenic Pimecrolimus-eluting Coronary Stent System
- ProGenic Pimecrolimus-eluting Coronary Stent System Product Overview
- Renamic Neo Programmer
- Renamic Neo Programmer Product Overview
- Solvia Rise
- Solvia Rise Product Overview
- Solvia Rise Clinical Trial
- Truelock
- Truelock Product Overview
- Truvia
- Truvia Product Overview
- Biotronik SE & Co KG - Key Competitors
- Biotronik SE & Co KG - Key Employees
- Biotronik SE & Co KG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Biotronik SE & Co KG, Recent Developments
- May 17, 2024: BIOMAG-I Two-Year Study Results Confirm Excellent Safety and Efficacy Profile for Freesolve, BIOTRONIK’s Newest Resorbable Magnesium Scaffold Innovation
- May 13, 2024: New-Gen Resorbable Magnesium Scaffold Freesolve Enters BIOMAG-II Randomized Controlled Trial (RCT)
- May 08, 2024: Biotronik SE Receives Additional Humanitarian Device Exemption (HDE) clearance for PK Papyrus Covered Coronary Stent
- Apr 13, 2024: Biotronik SE & Co Receives Additional Humanitarian Device Exemption (HDE) Clearance for PK Papyrus Covered Coronary Stent
- Mar 18, 2024: FDA Breakthrough Device Designation for BIOTRONIK Freesolve™ Below-the-Knee Resorbable Magnesium Scaffold (RMS)
- Feb 08, 2024: New BIOlMASTER.Selectra 3D Study Highlights Exceptional Safety and Performance of BIOTRONIK’s Selectra 3D Guiding Catheter for CSP
- Jan 29, 2024: BIOTRONIK's DX Technology Reaches Significant Milestone: 100,000 DX Devices Implanted
- Oct 26, 2023: Five-Year Superiority Proven for Orsiro Des Over Xience Des in Stemi Patients
- Oct 05, 2023: Newly Published Data Supports Effectiveness of BIOTRONIK Neuro’s RESONANCE Stimulation
- Sep 14, 2023: BIOLUX P-III BENELUX All-Comers Registry Demonstrates Safety and Efficacy of BIOTRONIK’s Drug-Coated Balloon in Isolated Popliteal Lesions at 24 Months
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
- Biotronik SE & Co KG Pipeline Products by Equipment Type
- Biotronik SE & Co KG Pipeline Products by Indication
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
- Biotronik SE & Co KG, Key Facts
- Biotronik SE & Co KG, Major Products and Services
- Biotronik SE & Co KG Number of Pipeline Products by Development Stage
- Biotronik SE & Co KG Pipeline Products Summary by Development Stage
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
- Biotronik SE & Co KG Ongoing Clinical Trials Summary
- AI Based Telemedicine - Myocardial Infarction - Product Status
- AI Based Telemedicine - Myocardial Infarction - Product Description
- Allevia - Product Status
- Allevia - Product Description
- AMS-2 - Product Status
- AMS-2 - Product Description
- Amvia Stellar - Product Status
- Amvia Stellar - Product Description
- BIOVALVE Resheathable Transcatheter Aortic Valve - Product Status
- BIOVALVE Resheathable Transcatheter Aortic Valve - Product Description
- Cardiac Conduction System - Product Status
- Cardiac Conduction System - Product Description
- Coronary Stent System - Product Status
- Coronary Stent System - Product Description
- Delivr - Product Status
- Delivr - Product Description
- DREAMS 3G System - Product Status
- DREAMS 3G System - Product Description
- DREAMS 3G System - BIOTRONIK - Safety and Clinical Performance of the - Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries
- DREAMS 3G System - BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A Randomized Controlled Trial
- ElePulse System - Product Status
- ElePulse System - Product Description
- ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
- Freesolve BTK RMS - Product Status
- Freesolve BTK RMS - Product Description
- Hatriq - Product Status
- Hatriq - Product Description
- Implantable Pressure Sensor - Product Status
- Implantable Pressure Sensor - Product Description
- Magmaris Bioresorbable Magnesium Scaffold - Product Status
- Magmaris Bioresorbable Magnesium Scaffold - Product Description
- Magmaris Bioresorbable Magnesium Scaffold - Biotroniks - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV
- Magmaris Bioresorbable Magnesium Scaffold - Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds Magmaris (MAGIC Registry)
- Magmaris Bioresorbable Magnesium Scaffold - RMS (Resorbable Magnesium Scaffolds) Registry
- Magmaris Bioresorbable Magnesium Scaffold - Scaffold Implantation in Emilia-Romagna
- ProGenic Pimecrolimus-eluting Coronary Stent System - Product Status
- ProGenic Pimecrolimus-eluting Coronary Stent System - Product Description
- Renamic Neo Programmer - Product Status
- Renamic Neo Programmer - Product Description
- Solvia Rise - Product Status
- Solvia Rise - Product Description
- Solvia Rise - BIO|CONCEPT.Amvia, First in Human Study for the Amvia/Solvia Pacemaker Family
- Solvia Rise - BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
- Truelock - Product Status
- Truelock - Product Description
- Truvia - Product Status
- Truvia - Product Description
- Biotronik SE & Co KG, Key Employees
- Biotronik SE & Co KG, Subsidiaries
- Glossary
- Biotronik SE & Co KG Pipeline Products by Equipment Type
- Biotronik SE & Co KG Pipeline Products by Development Stage
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Plc
- Medico SPA
- Acandis GmbH & Co KG
- Abbott Laboratories
- Eurocor Tech GmbH
